The drug Acitonal-35 has the main active ingredient, Risedronate sodium and other excipients in a sufficient amount. Acitonal-35 belongs to the group of antipyretic, analgesic, and anti-inflammatory non-steroid drugs. The drug is used to treat and prevent osteoporosis in postmenopausal women, maintain or increase bone mass in postmenopausal women requiring long-term treatment, and Paget's disease of bone.